This webinar is a recorded presentation of a live broadcast and includes the recorded presentation, the audience QA, and pdf handout. If you would like continuing education credit for the webinar, click on the links in the table below to access the webinar + CME/CMLE or webinar + SAM.



Eric H. Bernicker, MD


Christopher R. Gilbert, DO, MS, FCCP


Targeted therapies for advanced lung cancers continue to expand rapidly. Viewers of this presentation will get an overview of the latest developments in the management of oncogene-addicted lung cancers and the need for close collaboration between medical oncologists and pathologists to make sure that patients receive optimal therapy.

Duration: 1 hr

Level of Instruction: Basic

This webinar is part 2 of a five-part series aimed at breaking down barriers to NSCLC testing and treatment. If you'd like more information about the series go here.


Duration: 1 hr

Level of Instruction: Basic

Supported by an educational grant provided by AstraZeneca

Click on the links below to purchase continuing education credit.

Credit Type Number of Credit Hours Click on link to purchase:

Purchase Webinar + CME/CMLE

(Free for all)

SAM 1.0

Purchase Webinar + SAM

(Free for all)

Continuing Education Credit must be purchased and claimed by December 31, 2020


* You may not submit SAMs and CME/CMLE credit for the same content.

You may also be interested in:


Note: Members of AMP can access many of the webinars at no cost or a deep discount. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

Course Information
Course Date:
June 20, 2018
Course Objectives
  • Explain how targeted therapies are selected for patients with advanced adenocarcinoma of the lung.
  • Discuss the need for repeat biopsies upon progression so that therapies that target mechanisms of acquired resistance can be appropriately utilized.
Pre-Test for Best Practices in NSCLC Small Specimen Collection for Clinicians
Best Practices in NSCLC Small Specimen Collection for Clinicians
Post-Test for Best Practices in NSCLC Small Specimen Collection for Clinicians
QA Session
Individual topic purchase: Selected
Bernicker Presentation
AMP Regular Member: $0.00
AMP Technologist Member: $0.00
AMP Associate Member: $0.00
Non-member Price: $0.00